Literature DB >> 16888002

A pathogenic role for CD8+ T cells in a spontaneous model of demyelinating disease.

Marcel Brisebois1, Simone P Zehntner, José Estrada, Trevor Owens, Sylvie Fournier.   

Abstract

Transgenic (Tg) mice that overexpress the costimulatory ligand B7.2/CD86 on microglia spontaneously develop a T cell-mediated demyelinating disease. Characterization of the inflammatory infiltrates in the nervous tissue revealed a predominance of CD8+ T cells, suggesting a prominent role of this T cell subset in the pathology. In this study, we show that the same neurological disease occurred in Tg mice deficient in the generation of CD4+ T cells, with an earlier time of onset. Analysis of the CD8+ T cell repertoire at early stage of disease revealed the presence of selected clonal expansions in the CNS but not in peripheral lymphoid organs. We further show that Tg animals deficient in IFN-gamma receptor expression were completely resistant to disease development. Microglia activation that is an early event in disease development is IFN-gamma dependent and thus appears as a key element in disease pathogenesis. Collectively, our data indicate that the spontaneous demyelinating disease in this animal model occurs as a consequence of an inflammatory response initiated through the activation of CNS-specific CD8+ T cells by Tg expression of B7.2 within the target organ. Thus, autoreactive CD8+ T cells can contribute directly to the pathogenesis of neuroinflammatory diseases such as multiple sclerosis.

Entities:  

Mesh:

Year:  2006        PMID: 16888002     DOI: 10.4049/jimmunol.177.4.2403

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients.

Authors:  Raphael Schneider; Alma Nazlie Mohebiany; Igal Ifergan; Diane Beauseigle; Pierre Duquette; Alexandre Prat; Nathalie Arbour
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

2.  Induction of polyclonal CD8+ T cell activation and effector function by Pertussis toxin.

Authors:  Cathi Murphey; Steve Chang; Xue Zhang; Bernard Arulanandam; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2010-11-13       Impact factor: 4.868

Review 3.  Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a review.

Authors:  Archana A Gupta; Di Ding; Richard K Lee; Robert B Levy; Sanjoy K Bhattacharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

Review 4.  Transgenic mouse models of multiple sclerosis.

Authors:  Tanja Scheikl; Béatrice Pignolet; Lennart T Mars; Roland S Liblau
Journal:  Cell Mol Life Sci       Date:  2010-08-17       Impact factor: 9.261

Review 5.  Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.

Authors:  Lennart T Mars; Philippe Saikali; Roland S Liblau; Nathalie Arbour
Journal:  Biochim Biophys Acta       Date:  2010-07-15

Review 6.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

7.  Experimental Autoimmune Encephalomyelitis in Mice.

Authors:  Rachael L Terry; Igal Ifergan; Stephen D Miller
Journal:  Methods Mol Biol       Date:  2016

Review 8.  Disease-modifying agents for multiple sclerosis: recent advances and future prospects.

Authors:  Til Menge; Martin S Weber; Bernhard Hemmer; Bernd C Kieseier; Hans-Christian von Büdingen; Clemens Warnke; Scott S Zamvil; Aaron Boster; Omar Khan; Hans-Peter Hartung; Olaf Stüve
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  Modeling multiple sclerosis in laboratory animals.

Authors:  Bettina Schreiner; Frank L Heppner; Burkhard Becher
Journal:  Semin Immunopathol       Date:  2009-10-03       Impact factor: 9.623

10.  Pathogenic CD8 T cells in multiple sclerosis and its experimental models.

Authors:  Eric S Huseby; Priya G Huseby; Shivanee Shah; Rebecca Smith; Brian D Stadinski
Journal:  Front Immunol       Date:  2012-03-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.